Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification

Journal of Gynecologic Oncology

Volumn 20, Issue 1, 2009, Pages 17-21

  Kim, Woo Young ^a   Chang, Suk Joon ^a   Chang, Ki Hong ^a   Yoo, Seung Chul ^a   Chun, Mison ^a   Ryu, Hee Sug ^a  

^a Ajou University Medical CentSuwon   (South Korea)

Author keywords

Concurrent chemoradiation; Consolidation chemotherapy; High risk factor; Treatment modification

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIARRHEA; DIET THERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL TOXICITY; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; PELVIS LYMPH NODE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION INJURY; RADICAL HYSTERECTOMY; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT FAILURE; UTERINE CERVIX CANCER;

EID: 77953447550     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2009.20.1.17     Document Type: Article

References (23)

1. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-13.
2. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46:507-10.
3. Hsu CT, Cheng YS, Su SC. Prognosis of uterine cervical cancer with extensve lymph node metastases: special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol 1972; 114: 954-62.
4. Nahhas WA, Sharkey FE, Whitney CW, Husseinzadeh N, Chung CK, Mortel R. The prognostic significance of vascular channel involvement and deep stromal penetration in early cervical carcinoma. Am J Clin Oncol 1983; 6: 259-64.
5. Martimbeau PW, Kjorstad KE, Iversen T. Stage IB carcinoma of the cervix, the Norwegian Radium hospital: II. Results when pelvic nodes are involved. Obstet Gynecol 1982; 60: 215-8.
6. Van Nagel JR Jr, Donaldson ES, Parker JC, Van Dyke AH, Wood EG. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Gynecol Oncol 1977; 5: 142-51.
7. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study, Gynecol Oncol 1990; 38: 352-7.
8. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, 11A, and IIB. Cancer 1990; 65: 1923-7.
9. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.
10. Ryu HS, Chun M, Chang KH, Chang HJ, Lee JP. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 2005; 96: 490-5.
11. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999; 73: 106-10.
12. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998; 91: 360-3.
13. Samlal RA, van der Velden J, Schilthuis MS, Gonzalez Gonzalez D, Ten Kate FJ, Hart AA, et al. Identification of high-risk Groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol 1997; 64: 463-7.
14. Tinga DJ, Timmer PR, Bouma J, Aalders JG. Prognostic significancc of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 1990; 39: 175-80.
15. Stock RG, Chen AS, Flickinger JC, Kalnicki S, Seski J. Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure. IntJ Radiat Oncol Biol Phys 1995; 31: 31-6.
16. Lin HH, Cheng WF, Chan KW, Chang DY, Chen CK, Huang SC. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and post-operative pelvic irradiation. Obstet Gynecol 1996; 88: 274-9.
17. Wertheim MS, Hakes TB, Daghestani AN, Nori D, Smith DH, Lewis JL Jr. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 1985; 3: 912-6.
18. Houvenaeghel G, Lelievre L, Rigouard AL, Buttarelli M, Jacquernier J, Viens P, et al. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer. Gynecol Oncol 2006; 102: 74-9.
19. Choi CH, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, et al. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results. Int J Radiat Oncol Biol Phys 2007; 68: 817-22.
20. Wong LC, Choo YC, Choy D, Sham JS, Ma HK. Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecol Oncol 1989; 35: 159-63.
21. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology Group trial (RTOG) 90-01. J Clin Oncol 2004; 22: 872-80.
22. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-48.
23. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53.